Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 6 | 2022 | 15 | 1.600 |
Why?
|
| Neuralgia | 3 | 2020 | 7 | 0.960 |
Why?
|
| Complex Regional Pain Syndromes | 5 | 2022 | 18 | 0.840 |
Why?
|
| Ganglia, Spinal | 6 | 2022 | 49 | 0.750 |
Why?
|
| Analgesia, Epidural | 7 | 2003 | 48 | 0.550 |
Why?
|
| Chronic Pain | 4 | 2022 | 109 | 0.530 |
Why?
|
| Equipment Failure | 1 | 2016 | 38 | 0.520 |
Why?
|
| Ketamine | 2 | 2018 | 25 | 0.490 |
Why?
|
| Pain, Postoperative | 7 | 2003 | 293 | 0.450 |
Why?
|
| Analgesics | 6 | 2018 | 77 | 0.450 |
Why?
|
| Electric Stimulation Therapy | 4 | 2018 | 39 | 0.400 |
Why?
|
| Low Back Pain | 3 | 2022 | 112 | 0.360 |
Why?
|
| Humans | 36 | 2022 | 25692 | 0.280 |
Why?
|
| Pain Management | 4 | 2018 | 136 | 0.230 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2003 | 20 | 0.220 |
Why?
|
| Pain | 7 | 2022 | 372 | 0.210 |
Why?
|
| Denmark | 1 | 2020 | 9 | 0.180 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2012 | 26 | 0.170 |
Why?
|
| Pain Measurement | 7 | 2022 | 415 | 0.160 |
Why?
|
| Spinal Stenosis | 1 | 2018 | 30 | 0.150 |
Why?
|
| Anesthesiologists | 1 | 2018 | 6 | 0.150 |
Why?
|
| Anesthesia, Conduction | 1 | 2018 | 30 | 0.150 |
Why?
|
| Pain, Intractable | 2 | 2007 | 6 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2018 | 138 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 284 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2022 | 1633 | 0.130 |
Why?
|
| Spinal Fusion | 1 | 2022 | 434 | 0.120 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 11 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 1781 | 0.120 |
Why?
|
| Consensus | 3 | 2022 | 90 | 0.120 |
Why?
|
| Thoracotomy | 1 | 1994 | 25 | 0.120 |
Why?
|
| Lactones | 2 | 2005 | 9 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 46 | 0.120 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2005 | 27 | 0.120 |
Why?
|
| Morphine | 2 | 1992 | 60 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2022 | 3220 | 0.110 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 18 | 0.090 |
Why?
|
| Anesthesia, Epidural | 1 | 2011 | 19 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 39 | 0.090 |
Why?
|
| Warfarin | 1 | 2011 | 25 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 26 | 0.090 |
Why?
|
| Female | 15 | 2022 | 14273 | 0.090 |
Why?
|
| Nerve Block | 3 | 2000 | 63 | 0.080 |
Why?
|
| Adult | 11 | 2022 | 7336 | 0.080 |
Why?
|
| Benzocaine | 2 | 2000 | 4 | 0.080 |
Why?
|
| Middle Aged | 10 | 2022 | 8403 | 0.080 |
Why?
|
| Narcotics | 1 | 1990 | 35 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 170 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2000 | 78 | 0.080 |
Why?
|
| Neoplasms | 2 | 1998 | 224 | 0.080 |
Why?
|
| Sulfones | 2 | 2005 | 18 | 0.080 |
Why?
|
| Terrorism | 1 | 2007 | 14 | 0.070 |
Why?
|
| Analgesia | 1 | 2007 | 34 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2007 | 71 | 0.070 |
Why?
|
| Reflex Sympathetic Dystrophy | 2 | 1996 | 2 | 0.070 |
Why?
|
| Male | 12 | 2022 | 13917 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 49 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2007 | 166 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 3231 | 0.060 |
Why?
|
| Sympatholytics | 2 | 2010 | 7 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 51 | 0.050 |
Why?
|
| Clonidine | 2 | 1996 | 17 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 209 | 0.050 |
Why?
|
| Sacroiliac Joint | 1 | 2022 | 9 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2022 | 62 | 0.050 |
Why?
|
| Aged | 6 | 2022 | 8501 | 0.050 |
Why?
|
| Device Removal | 1 | 2022 | 85 | 0.050 |
Why?
|
| Fentanyl | 2 | 1994 | 22 | 0.050 |
Why?
|
| Bupivacaine | 2 | 1994 | 42 | 0.050 |
Why?
|
| Celiac Plexus | 1 | 2000 | 1 | 0.050 |
Why?
|
| Extremities | 2 | 1996 | 23 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 89 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 341 | 0.040 |
Why?
|
| Injections, Epidural | 1 | 2018 | 12 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 112 | 0.040 |
Why?
|
| Thermography | 1 | 1996 | 14 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2003 | 568 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1996 | 3 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 12 | 0.030 |
Why?
|
| Blood Pressure | 3 | 1996 | 185 | 0.030 |
Why?
|
| Anesthesia, Spinal | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2015 | 24 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 280 | 0.030 |
Why?
|
| Chronic Disease | 4 | 1998 | 403 | 0.030 |
Why?
|
| Yohimbine | 2 | 1996 | 6 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 291 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1994 | 130 | 0.030 |
Why?
|
| United States | 1 | 2018 | 1943 | 0.020 |
Why?
|
| Algorithms | 1 | 1994 | 347 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 45 | 0.020 |
Why?
|
| Oxygen | 1 | 1992 | 74 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 21 | 0.020 |
Why?
|
| Guanethidine | 1 | 2010 | 1 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1991 | 45 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 5 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1992 | 93 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 61 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 1990 | 3 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 75 | 0.020 |
Why?
|
| Nociceptors | 1 | 1990 | 19 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 64 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 1855 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 472 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 329 | 0.020 |
Why?
|
| Time Factors | 1 | 1992 | 1336 | 0.020 |
Why?
|
| Embolism, Air | 1 | 1988 | 10 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 646 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 26 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4459 | 0.020 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 9 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 55 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 124 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2003 | 396 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 170 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 153 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 1996 | 156 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2005 | 55 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 739 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 618 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 103 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2007 | 827 | 0.010 |
Why?
|
| Stress, Psychological | 2 | 1996 | 211 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 201 | 0.010 |
Why?
|
| Dyssomnias | 1 | 2003 | 6 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 23 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 26 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 19 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 14 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2003 | 52 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2003 | 43 | 0.010 |
Why?
|
| Injections, Spinal | 2 | 1996 | 30 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1176 | 0.010 |
Why?
|
| Reaction Time | 2 | 1996 | 104 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 499 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 151 | 0.010 |
Why?
|
| Hemodynamics | 2 | 1996 | 57 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 284 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 625 | 0.010 |
Why?
|
| Suspensions | 1 | 1998 | 3 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 69 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1996 | 9 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1996 | 28 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 36 | 0.010 |
Why?
|
| Body Temperature | 1 | 1996 | 44 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 16 | 0.010 |
Why?
|
| Biofeedback, Psychology | 1 | 1996 | 3 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1996 | 17 | 0.010 |
Why?
|
| Pain Clinics | 1 | 1996 | 3 | 0.010 |
Why?
|
| Behavior | 1 | 1996 | 22 | 0.010 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1996 | 17 | 0.010 |
Why?
|
| Dioxanes | 1 | 1996 | 2 | 0.010 |
Why?
|
| Glycopyrrolate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Idazoxan | 1 | 1996 | 2 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 4 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1996 | 12 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1996 | 55 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 28 | 0.010 |
Why?
|
| Bradycardia | 1 | 1996 | 18 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 84 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1996 | 61 | 0.010 |
Why?
|
| Learning | 1 | 1996 | 67 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 176 | 0.010 |
Why?
|
| Animals | 2 | 1996 | 3510 | 0.010 |
Why?
|
| Imidazoles | 1 | 1996 | 53 | 0.010 |
Why?
|
| Family | 1 | 1996 | 94 | 0.010 |
Why?
|
| Heart Rate | 1 | 1996 | 109 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 281 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 325 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 90 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1992 | 11 | 0.010 |
Why?
|
| Reperfusion | 1 | 1992 | 7 | 0.010 |
Why?
|
| Oximetry | 1 | 1992 | 12 | 0.010 |
Why?
|
| Hypotension | 1 | 1992 | 23 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1992 | 56 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 43 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 1077 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 69 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 104 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 23 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1988 | 19 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1988 | 9 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1988 | 34 | 0.000 |
Why?
|
| Epidural Space | 1 | 1988 | 20 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 649 | 0.000 |
Why?
|
| Cognition | 1 | 1996 | 1265 | 0.000 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.000 |
Why?
|
| Veins | 1 | 1988 | 9 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 116 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1988 | 38 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 235 | 0.000 |
Why?
|
| Incidence | 1 | 1988 | 731 | 0.000 |
Why?
|
| Hip Joint | 1 | 1988 | 492 | 0.000 |
Why?
|